Abstract:ABSTRACT In a healthy colon, the stratified mucus layer serves as a crucial innate immune barrier to protect the epithelium from microbes. Mucins are complex glycoproteins that serve as a nutrient source for resident microflora and can be exploited by pathogens. We aimed to understand how the intestinal pathogen, Clostridioides difficile , independently uses or manipulates mucus to its benefit, without contributions from members of the microbiota. Using a 2-D primary human intestinal epithelial cell model to generate physiologic mucus, we assessed C. difficile- mucus interactions through growth assays, RNA-Seq, biophysical characterization of mucus, and contextualized metabolic modeling. We found that host-derived mucus promotes C. difficile growth both in vitro and in an infection model. RNA-Seq revealed significant upregulation of genes related to central metabolism in response to mucus, including genes involved in sugar uptake, the Wood-Ljungdahl pathway, and the glycine cleavage system. In addition, we identified differential expression of genes related to sensing and transcriptional control. Analysis of mutants with deletions in highly upregulated genes reflected the complexity of C. difficile -mucus interactions, with potential interplay between sensing and growth. Mucus also stimulated biofilm formation in vitro , which may in turn alter the viscoelastic properties of mucus. Context-specific metabolic modeling confirmed differential metabolism and the predicted importance of enzymes related to serine and glycine catabolism with mucus. Subsequent growth experiments supported these findings, indicating mucus is an important source of serine. Our results better define responses of C. difficile to human gastrointestinal mucus and highlight flexibility in metabolism that may influence pathogenesis. IMPORTANCE Clostridioides difficile results in upward of 250,000 infections and 12,000 deaths annually in the United States. Community-acquired infections continue to rise, and recurrent disease is common, emphasizing a vital need to understand C. difficile pathogenesis. C. difficile undoubtedly interacts with colonic mucus, but the extent to which the pathogen can independently respond to and take advantage of this niche has not been explored extensively. Moreover, the metabolic complexity of C. difficile remains poorly understood but likely impacts its capacity to grow and persist in the host. Here, we demonstrate that C. difficile uses native colonic mucus for growth, indicating C. difficile possesses mechanisms to exploit the mucosal niche. Furthermore, mucus induces metabolic shifts and biofilm formation in C. difficile , which has potential ramifications for intestinal colonization. Overall, our work is crucial to better understand the dynamics of C. difficile -mucus interactions in the context of the human gut.

Flagellar motility and the mucus environment influence aggregation mediated antibiotic tolerance of in chronic lung infection

Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection

Exploring aggregation genes in a chronic infection model

Flagellin Shifts 3D Bronchospheres Towards Mucus Hyperproduction

Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa

Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus.

Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions That Promotes Disease Persistence.

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis

Reduced Three-Dimensional Motility in Dehydrated Airway Mucus Prevents Neutrophil Capture and Killing Bacteria on Airway Epithelial Surfaces

Modeling Cystic Fibrosis Chronic Infection Using Engineered Mucus-like Hydrogels

faces a fitness trade-off between mucosal colonization and antibiotic tolerance during airway infections

Mycobacterium abscessus persistence in the face of Pseudomonas aeruginosa antagonism

MUC5AC drives COPD exacerbation severity through amplification of virus-induced airway inflammation

Macrolide resistance through uL4 and uL22 ribosomal mutations in

Antibacterial potential of Stenotrophomonas maltophilia complex cystic fibrosis isolates

Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms

Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment

Clostridioides difficile-mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation

Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding

Homogentisate 1-2-Dioxygenase Downregulation in the Chronic Persistence of Pseudomonas aeruginosa Australian Epidemic Strain-1 in the CF Lung

Autoaggregation in is driven by the Pel polysaccharide